New Mantle Cell Lymphoma treatments improving survival and response rates

Ongoing clinical research at MD Anderson is finding promising new therapies for a rare and aggressive type of lymphoma that becomes resistant to treatment. Although mantle cell lymphoma (MCL) currently has no cure, combinations of new targeted therapy drugs are dramatically improving survival and treatment response rates for MCL patients.

Guests: Michael Wang, M.D. and Jorge Romaguera, M.D.

• Download New Mantle Cell Lymphoma treatments improving survival and response rates from iTunes
• Click here for a transcript of this episode